Cite
HARVARD Citation
Itoh, K. et al. (2018). Randomized phase II study of a bendamustine monotherapy schedule for relapsed or refractory low-grade B-cell non-Hodgkin lymphoma or mantle cell lymphoma (RABBIT-14). Leukemia & lymphoma. 59 (7), pp. 1606-1613. [Online].